Login to Your Account

Former Durata execs secure $40M series A, join anti-infectives race 'Iterum'

By Marie Powers
News Editor

Thursday, March 24, 2016

Frazier Healthcare Partners led the $40 million series A to launch Iterum Therapeutics Ltd., which will focus on in-licensing and developing anti-infective candidates targeting multidrug-resistant pathogens.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription